CDRH Compliance Office Seeks Inroads With FDA Office Of Regulatory Affairs
This article was originally published in The Gray Sheet
Executive Summary
The top near-term contribution of the Office of Compliance to CDRH's postmarket reform effort will be trying to improve its working relationship with FDA's Office of Regulatory Affairs